Table 4 Adjusted risk, in percentages, of mortality (95% confidence intervals) for each patient factor and SNF cluster
Patient factor | SNF group | ||||
|---|---|---|---|---|---|
1 | 2 | 3 | 4 | p | |
1–Congestive heart failure | 20.2 19.9–20.5 | 18.8 18.4–19.2 | 19.2 18.8–19.5 | 20.2 19.7–20.6 | < 0.001 |
2–Non-hematological solid tumor | 20.9 20.5–21.2 | 20.8 20.2–21.3 | 21.1 20.7–21.6 | 21.2 20.6–21.8 | 0.40 |
3–Asthma | 17.0 16.7–17.3 | 16.7 16.3–17.0 | 16.6 16.2–16.9 | 17.0 16.6–17.4 | 0.28 |
4–Osteoarthritis | 5.0 4.9–5.1 | 5.2 5.1–5.3 | 5.3 5.2–5.4 | 5.0 4.9–5.2 | < 0.001 |
5–HIV | 11.4 8.1–14.6 | 11.6 8.4–14.7 | 13.7 10.2–17.2 | 13.2 7.9–18.5 | 0.73 |
6–Liver disease | 17.8 17.3–18.3 | 17.1 16.4–17.8 | 17.2 16.5–17.8 | 17.7 16.9–18.5 | 0.29 |
7–Chronic skin ulcer | 15.6 15.4–15.9 | 16.4 16.0-16.7 | 15.5 15.2–15.8 | 16.2 15.8–16.6 | < 0.001 |
8–Depression and depressive disorders | 11.1 10.9–11.3 | 10.6 10.4–10.9 | 10.9 10.6–11.1 | 11.2 10.9–11.5 | 0.007 |
9–Hematological cancer | 21.6 20.7–22.4 | 21.3 20.1–22.5 | 21.2 20.2–22.3 | 22.1 20.7–23.4 | 0.82 |
10–Chronic renal failure | 15.8 15.5–16.0 | 15.9 15.5–16.2 | 15.5 15.2–15.8 | 15.9 15.6–16.3 | 0.21 |
11–Hyperlipidemia | 13.7 13.5–13.9 | 13.7 13.4–14.0 | 13.6 13.3–13.8 | 13.9 13.6–14.2 | 0.81 |
12–Other musculoskeletal including osteoporosis | 11.2 11.0-11.4 | 11.2 11.0-11.5 | 11.3 11.0-11.5 | 11.2 10.9–11.5 | 0.63 |